US 10350292
Agonist antibodies that bind human CD137 and uses thereof
granted A61KA61K2039/572A61K35/17
Quick answer
US patent 10350292 (Agonist antibodies that bind human CD137 and uses thereof) held by Compass Therapeutics LLC expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/572, A61K35/17, A61K39/001117, A61K39/39558